331 related articles for article (PubMed ID: 7595219)
1. The use of mammary tumor virus (Mtv)-negative and single-Mtv mice to evaluate the effects of endogenous viral superantigens on the T cell repertoire.
Scherer MT; Ignatowicz L; Pullen A; Kappler J; Marrack P
J Exp Med; 1995 Nov; 182(5):1493-504. PubMed ID: 7595219
[TBL] [Abstract][Full Text] [Related]
2. Thymic repertoire selection by superantigens: presentation by human and mouse MHC molecules.
Simpson E; Takacs K; Altmann DM
Thymus; 1994; 23(1):1-13. PubMed ID: 7863543
[TBL] [Abstract][Full Text] [Related]
3. Synchronous deletion of Mtv-superantigen-reactive thymocytes in the CD3(medium/high) CD4(+)CD8(+) subset.
Sheard MA; Sharrow SO; Takahama Y
Scand J Immunol; 2000 Dec; 52(6):550-4. PubMed ID: 11119259
[TBL] [Abstract][Full Text] [Related]
4. Identification of two V beta 7-specific viral superantigens.
Ignatowicz L; Kappler JW; Marrack P; Scherer MT
J Immunol; 1994 Jan; 152(1):65-71. PubMed ID: 8254207
[TBL] [Abstract][Full Text] [Related]
5. T cell receptor V beta repertoire in mice lacking endogenous mouse mammary tumor provirus.
Braun MY; Jouvin-Marche E; Marche PN; MacDonald HR; Acha-Orbea H
Eur J Immunol; 1995 Mar; 25(3):857-62. PubMed ID: 7705418
[TBL] [Abstract][Full Text] [Related]
6. Peripheral T cell activation and deletion induced by transfer of lymphocyte subsets expressing endogenous or exogenous mouse mammary tumor virus.
Waanders GA; Shakhov AN; Held W; Karapetian O; Acha-Orbea H; MacDonald HR
J Exp Med; 1993 May; 177(5):1359-66. PubMed ID: 8386743
[TBL] [Abstract][Full Text] [Related]
7. Deletion of peripheral V beta 14+ T cells by Mtv-2-encoded viral superantigen preceded by blastogenesis and DNA synthesis but not by specific expansion.
Nakano H; Yoshimoto T; Nariuchi H; Kakiuchi T; Matsuzawa A
Cell Immunol; 1996 Mar; 168(2):281-90. PubMed ID: 8640876
[TBL] [Abstract][Full Text] [Related]
8. Identification of key amino acids of the mouse mammary tumor virus superantigen involved in the specific interaction with T-cell receptor V(beta) domains.
Baribaud F; Wirth S; Maillard I; Valsesia S; Acha-Orbea H; Diggelmann H
J Virol; 2001 Aug; 75(16):7453-61. PubMed ID: 11462017
[TBL] [Abstract][Full Text] [Related]
9. Expression of two structurally identical viral superantigens results in thymic elimination at distinct developmental stages.
Morishima C; Norby-Slycord C; McConnell KR; Finch RJ; Nelson AJ; Farr AG; Pullen AM
J Immunol; 1994 Dec; 153(11):5091-103. PubMed ID: 7963568
[TBL] [Abstract][Full Text] [Related]
10. I-J revisited: is the I-J genetic restriction in downregulation due to an endogenous superantigen analogous to mammary tumour virus (Mtv)-encoded endogenous superantigen?
Asherson GL; Dieli F; Tomonari K
Folia Biol (Praha); 1994; 40(6):341-7. PubMed ID: 7589693
[TBL] [Abstract][Full Text] [Related]
11. T cell repertoire and clonal deletion of Mtv superantigen-reactive T cells in mice lacking CD4 and CD8 molecules.
Penninger JM; Schilham MW; Timms E; Wallace VA; Mak TW
Eur J Immunol; 1995 Jul; 25(7):2115-8. PubMed ID: 7621886
[TBL] [Abstract][Full Text] [Related]
12. V beta 17 T-cell deletion by endogenous mammary tumor virus in wild-type-derived mouse strain.
Jouvin-Marche E; Cazenave PA; Voegtle D; Marche PN
Proc Natl Acad Sci U S A; 1992 Apr; 89(8):3232-5. PubMed ID: 1314381
[TBL] [Abstract][Full Text] [Related]
13. Differences in the avidity of TCR interactions with a superantigenic ligand affect negative selection but do not allow positive selection.
Chervonsky AV; Golovkina TV; Ross SR; Janeway CA
J Immunol; 1995 Dec; 155(11):5115-23. PubMed ID: 7594520
[TBL] [Abstract][Full Text] [Related]
14. Quantitation of endogenous mouse mammary tumor virus superantigen expression by lymphocyte subsets.
Waanders GA; Lees RK; Held W; MacDonald HR
Eur J Immunol; 1995 Sep; 25(9):2632-7. PubMed ID: 7589137
[TBL] [Abstract][Full Text] [Related]
15. CD4 regulates the efficiency of an endogenous superantigen-induced clonal deletion of TCRV beta 11+ cells in the periphery.
Kubo S; Hasegawa A; Hashimoto K; Shimizu C; Kubo M; Tada T; Nakayama T
Immunology; 1997 Dec; 92(4):437-46. PubMed ID: 9497484
[TBL] [Abstract][Full Text] [Related]
16. Divergent viral superantigens delete V beta 5+ T lymphocytes.
Gollob KJ; Palmer E
Proc Natl Acad Sci U S A; 1992 Jun; 89(11):5138-41. PubMed ID: 1317583
[TBL] [Abstract][Full Text] [Related]
17. Influence of viral superantigens on V beta- and V alpha-specific positive and negative selection.
Tomonari K; Fairchild S; Rosenwasser OA
Immunol Rev; 1993 Feb; 131():131-68. PubMed ID: 8387455
[TBL] [Abstract][Full Text] [Related]
18. Chronic deletion, escape from deletion and activation of mouse mammary tumor virus superantigen-reactive T cells in C57BL/10 mice.
Dyson PJ; Elliott JI
Eur J Immunol; 1999 May; 29(5):1456-66. PubMed ID: 10359099
[TBL] [Abstract][Full Text] [Related]
19. Rat T cell responses to superantigens. II. Allelic differences in V beta 8.2 and V beta 8.5 beta chains determine responsiveness to staphylococcal enterotoxin B and mouse mammary tumor virus-encoded products.
Gold DP; Surh CD; Sellins KS; Schroder K; Sprent J; Wilson DB
J Exp Med; 1994 Jan; 179(1):63-9. PubMed ID: 8270884
[TBL] [Abstract][Full Text] [Related]
20. Loss of endogenous mouse mammary tumor virus superantigen increases tumor resistance.
Schirrmacher V; Beutner U; Bucur M; Umansky V; Rocha M; von Hoegen P
J Immunol; 1998 Jul; 161(2):563-70. PubMed ID: 9670928
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]